NCT03076970 - Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan in Healthy Participants | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 21, 2017

Primary Completion Date

April 13, 2017

Study Completion Date

April 13, 2017

Conditions

Migraine

Interventions

DRUG

lasmiditan 200 mg

drug including single placebo tablet

DRUG

Sumatriptan

drug including single placebo tablet

DRUG

matching placebo

single oral tablet -given with single lasmiditan tablet and with single sumatriptan tablet.

Trial Locations (1)

SNBL Clinical Pharmacology Unit, Baltimore